Patents Assigned to InSight Innovations, LLC
-
Patent number: 10548766Abstract: Generally, an intraocular implant and methods for treating an ocular condition. As to certain embodiments, an intraocular biocompatible biodegradable implant (11) which can provide a biocompatible biodegradable material in the form of a flexible membrane (12) containing an active agent (24) which implanted between an intraocular lens (8) and the surface of the posterior capsule (5) of the eye (1)(4) inhibits migration of residual lens epithelial cells after cataract surgery by providing structural or pharmaceutical barriers to reduce posterior capsule (5) opacification of the eye (1)(4).Type: GrantFiled: September 19, 2016Date of Patent: February 4, 2020Assignee: INSIGHT INNOVATIONS, LLCInventor: Kevin H. Cuevas
-
Publication number: 20180228600Abstract: Generally, an intraocular implant having on the external surface a plurality of pattern surface elements disposed in spaced apart relation defining a tortuous pathway adapted to control a flow of fluid or a flow of particles suspended in a fluid or inhibit the growth or migration of cells is provided. In particular, an intraocular implant that is implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits growth or migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: ApplicationFiled: April 16, 2018Publication date: August 16, 2018Applicants: InSight Innovations, LLC, Sharklet Technologies, Inc., University of Florida Research Foundation, Inc.Inventors: Kevin H. CUEVAS, Shravanthi T. REDDY, Chelsea Marie MAGIN, Michael R. METTETAL, Anthony B. BRENNAN, Rhea Marie MAY, Ethan Eugene MANN
-
Patent number: 9943402Abstract: Generally, an intraocular implant having on the external surface a plurality of pattern surface elements disposed in spaced apart relation defining a tortuous pathway adapted to control a flow of fluid, or a flow of particles suspended in a fluid, or inhibits the growth or migration of cells. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits growth or migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: GrantFiled: August 7, 2015Date of Patent: April 17, 2018Assignees: Insight Innovations, LLC, Sharklet Technologies, Inc., University of Florida Research Foundation, Inc.Inventors: Kevin H. Cuevas, Shravanthi T. Reddy, Chelsea Marie Magin, Michael R. Mettetal, Anthony B. Brennan, Rhea Marie May, Ethan Eugene Mann
-
Patent number: 9943404Abstract: Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: GrantFiled: December 7, 2015Date of Patent: April 17, 2018Assignee: INSIGHT INNOVATIONS, LLCInventor: Kevin H. Cuevas
-
Patent number: 9855135Abstract: Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: GrantFiled: June 6, 2014Date of Patent: January 2, 2018Assignee: INSIGHT INNOVATIONS, LLCInventor: Kevin H. Cuevas
-
Publication number: 20170000644Abstract: Generally, an intraocular implant and methods for treating an ocular condition. As to certain embodiments, an intraocular biocompatible biodegradable implant (11) which can provide a biocompatible biodegradable material in the form of a flexible membrane (12) containing an active agent (24) which implanted between an intraocular lens (8) and the surface of the posterior capsule (5) of the eye (1)(4) inhibits migration of residual lens epithelial cells after cataract surgery by providing structural or pharmaceutical barriers to reduce posterior capsule (5) opacification of the eye (1)(4).Type: ApplicationFiled: September 19, 2016Publication date: January 5, 2017Applicant: InSight Innovations, LLCInventor: Kevin H. Cuevas
-
Publication number: 20160081792Abstract: Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: ApplicationFiled: December 7, 2015Publication date: March 24, 2016Applicant: InSight Innovations, LLCInventor: Kevin H. Cuevas
-
Patent number: 9204961Abstract: Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: GrantFiled: July 17, 2013Date of Patent: December 8, 2015Assignee: Insight Innovations, LLCInventor: Kevin H. Cuevas
-
Publication number: 20150342725Abstract: Generally, an intraocular implant having on the external surface a plurality of pattern surface elements disposed in spaced apart relation defining a tortuous pathway adapted to control a flow of fluid, or a flow of particles suspended in a fluid, or inhibits the growth or migration of cells. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits growth or migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: ApplicationFiled: August 7, 2015Publication date: December 3, 2015Applicants: InSight Innovations, LLC, Sharklet Technologies, Inc., University of FloridaInventors: Kevin H. Cuevas, Shravanthi T. Reddy, Chelsea Marie Magin, Michael R. Mettetal, Anthony B. Brennan, Rhea Marie May, Ethan Eugene Mann
-
Patent number: 8551167Abstract: Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.Type: GrantFiled: August 2, 2011Date of Patent: October 8, 2013Assignee: InSight Innovations, LLCInventor: Kevin H. Cuevas